185 related articles for article (PubMed ID: 32205469)
21. DNA methylation age acceleration is associated with age of onset in Chinese spinocerebellar ataxia type 3 patients.
Li J; Shu A; Sun Y; Yang W; Tang X; Pu H; Peng Y; Hu X; Qing Y; Wang J; Wan C; Zhou M; Zhang M
Neurobiol Aging; 2022 May; 113():1-6. PubMed ID: 35247757
[TBL] [Abstract][Full Text] [Related]
22. Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
Nóbrega C; Simões AT; Duarte-Neves J; Duarte S; Vasconcelos-Ferreira A; Cunha-Santos J; Pereira D; Santana M; Cavadas C; de Almeida LP
Adv Exp Med Biol; 2018; 1049():349-367. PubMed ID: 29427113
[TBL] [Abstract][Full Text] [Related]
23. Novel Machado-Joseph disease-modifying genes and pathways identified by whole-exome sequencing.
Raposo M; Bettencourt C; Melo ARV; Ferreira AF; Alonso I; Silva P; Vasconcelos J; Kay T; Saraiva-Pereira ML; Costa MD; Vilasboas-Campos D; Bettencourt BF; Bruges-Armas J; Houlden H; Heutink P; Jardim LB; Sequeiros J; Maciel P; Lima M
Neurobiol Dis; 2022 Jan; 162():105578. PubMed ID: 34871736
[TBL] [Abstract][Full Text] [Related]
24. Caring for Machado-Joseph disease: current understanding and how to help patients.
D'Abreu A; França MC; Paulson HL; Lopes-Cendes I
Parkinsonism Relat Disord; 2010 Jan; 16(1):2-7. PubMed ID: 19811945
[TBL] [Abstract][Full Text] [Related]
25. Recent therapeutic prospects for Machado-Joseph disease.
Costa MDC
Curr Opin Neurol; 2020 Aug; 33(4):519-526. PubMed ID: 32657894
[TBL] [Abstract][Full Text] [Related]
26. Machado-Joseph Disease: from first descriptions to new perspectives.
Bettencourt C; Lima M
Orphanet J Rare Dis; 2011 Jun; 6():35. PubMed ID: 21635785
[TBL] [Abstract][Full Text] [Related]
27. [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].
Jia D; Jiang H; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):660-2. PubMed ID: 19065526
[TBL] [Abstract][Full Text] [Related]
28. Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population.
Gan SR; Ni W; Dong Y; Wang N; Wu ZY
PLoS One; 2015; 10(8):e0134405. PubMed ID: 26266536
[TBL] [Abstract][Full Text] [Related]
29. Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease.
Takiyama Y; Igarashi S; Rogaeva EA; Endo K; Rogaev EI; Tanaka H; Sherrington R; Sanpei K; Liang Y; Saito M
Hum Mol Genet; 1995 Jul; 4(7):1137-46. PubMed ID: 8528200
[TBL] [Abstract][Full Text] [Related]
30. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
31. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis.
de Mattos EP; Kolbe Musskopf M; Bielefeldt Leotti V; Saraiva-Pereira ML; Jardim LB
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):203-210. PubMed ID: 30337442
[TBL] [Abstract][Full Text] [Related]
32. Toward understanding Machado-Joseph disease.
Costa Mdo C; Paulson HL
Prog Neurobiol; 2012 May; 97(2):239-57. PubMed ID: 22133674
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
[TBL] [Abstract][Full Text] [Related]
34. Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3.
Tsai HF; Liu CS; Chen GD; Lin ML; Li C; Chen YY; Wang BT; Hsieh M
J Clin Lab Anal; 2003; 17(5):195-200. PubMed ID: 12938149
[TBL] [Abstract][Full Text] [Related]
35. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-related network underlain by (CAG)n loci modulate age at onset in Machado-Joseph disease.
Chen Z; Wang C; Zheng C; Long Z; Cao L; Li X; Shang H; Yin X; Zhang B; Liu J; Ding D; Peng Y; Peng H; Ye W; Qiu R; Pan Q; Xia K; Chen S; Sequeiros J; Ashizawa T; Tang B; Jiang H;
Brain; 2017 Apr; 140(4):e25. PubMed ID: 28334945
[No Abstract] [Full Text] [Related]
37. Normal ATXN3 Allele but Not CHIP Polymorphisms Modulates Age at Onset in Machado-Joseph Disease.
França MC; Emmel VE; D'Abreu A; Maurer-Morelli CV; Secolin R; Bonadia LC; da Silva MS; Nucci A; Jardim LB; Saraiva-Pereira ML; Marques W; Paulson H; Lopes-Cendes I
Front Neurol; 2012; 3():164. PubMed ID: 23181052
[TBL] [Abstract][Full Text] [Related]
38. The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.
Bettencourt C; Santos C; Montiel R; Kay T; Vasconcelos J; Maciel P; Lima M
Eur J Hum Genet; 2010 May; 18(5):621-3. PubMed ID: 19935829
[TBL] [Abstract][Full Text] [Related]
39. Modifiers of (CAG)(n) instability in Machado-Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes.
Martins S; Pearson CE; Coutinho P; Provost S; Amorim A; Dubé MP; Sequeiros J; Rouleau GA
Hum Genet; 2014 Oct; 133(10):1311-8. PubMed ID: 25026993
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of FKH-2/FOXG1 is neuroprotective in a C. elegans model of Machado-Joseph disease.
Fardghassemi Y; Parker JA
Exp Neurol; 2021 Mar; 337():113544. PubMed ID: 33290777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
